Robeco Institutional Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,338
Closed -$312K 976
2021
Q2
$312K Hold
11,338
﹤0.01% 850
2021
Q1
$187K Buy
+11,338
New +$258K ﹤0.01% 881

Robeco Institutional Asset Management's TBIO Position: Q3 2021 in Review

Robeco Institutional Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 11,338 shares — an estimated $312K sold.

Robeco Institutional Asset Management first reported a position in TBIO in Q1 2021 and held it in 2 quarters. The position peaked at $312K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Robeco Institutional Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 11,338 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $312K.
  • Robeco Institutional Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Robeco Institutional Asset Management's Translate Bio, Inc. Common Stock position peaked at $312K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2021, filed 20 Oct 2021.